Abstract :
Bypass surgery has been shown to prolong life in patients with significant left main stenosis compared with medical therapy and is the current standard of care. Recent registry data suggest that stenting may offer intermediate-term results similar to surgery, although with a greater need for repeat revascularization. Drug-eluting stents appear to improve the outcomes of stenting. Over 20% of patients with left main disease currently receive stents, and there is need for ongoing randomized controlled trials to validate this approach. It is essential that such patients receive balanced counseling as to revascularization options.
Keywords :
BMS , PCI , DES , LAD , ITA , Percutaneous coronary intervention , CABG , left anterior descending coronary artery , ST , coronary artery bypass grafting , drug-eluting stent(s) , LM , left main coronary artery , stent thrombosis , bare-metal stent(s) , internal thoracic artery